| 3OC0: reference: Discovery of carmegliptin: A potent and long-acting dipeptidyl peptidase IV inhibitor for the treatment of type 2 diabetes., Mattei P, Boehringer M, Di Giorgio P, Fischer H, Hennig M, Huwyler J, Kocer B, Kuhn B, Loeffler BM, Macdonald A, Narquizian R, Rauber E, Sebokova E, Sprecher U, Bioorg Med Chem Lett. 2009 Dec 6. PMID: 20031405 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).